Thanks for the link, but I don't buy the, “extreme jeopardy” thesis vis-à-vis PDUFA fees. It’s simply not in anybody’s interest to break a system that pays for FDA reviews without resorting to taxpayer funding.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”